Investing.com - GlaxoSmithKline ADR reported on Wednesday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
GlaxoSmithKline ADR announced earnings per share of £0.23 on revenue of £8.74B. Analysts polled by Investing.com anticipated EPS of £0.6223 on revenue of £11.87B.
GlaxoSmithKline ADR shares are down 3.1% from the beginning of the year and are trading at £35.66 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
GlaxoSmithKline ADR shares lost 5.13% in intra-day trade the report.
GlaxoSmithKline ADR follows other major Healthcare sector earnings this month
GlaxoSmithKline ADR's report follows an earnings beat by J&J on January 26, who reported EPS of £1.86 on revenue of £22.48B, compared to forecasts EPS of £1.82 on revenue of £21.66B.
Abbott Labs had beat expectations on January 27 with fourth quarter EPS of £1.45 on revenue of £10.7B, compared to forecast for EPS of £1.35 on revenue of £9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar